No earnings within 2 weeks of this transaction.
| Insider | Henn Matthew R |
|---|---|
| Title | President and Chief Scientific Officer |
| Transaction Date | Aug 15, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Restricted Stock Units |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Aug 18, 2026 |
| Shares Purchased | 140 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 282 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-355718 |
| Document | View SEC Filing |